Derma Sciences Inc. (DSCI) Swings to Q4 Profit
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.
You May Also Be Interested In
- MannKind (MNKD) CCO Castagna Buys Shares
- Yintech Investment Holdings Limited (YIN) Reports Q2 EPS of RMB3.50; Guides Q3 Revenue
- Guess? (GES) Tops Q2 EPS by 7c; Guides Higher
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!